APA (7th ed.) Citation

A, Å., D, W., PG, S., L, W., SK, J., A, B., . . . RC, B. (2019). Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. Journal of thrombosis and thrombolysis, 48(4), 563. https://doi.org/10.1007/s11239-019-01938-2

Chicago Style (17th ed.) Citation

A, Åkerblom, et al. "Prevalence and Relevance of Abnormal Glucose Metabolism in Acute Coronary Syndromes: Insights from the PLATelet Inhibition and Patient Outcomes (PLATO) Trial." Journal of Thrombosis and Thrombolysis 48, no. 4 (2019): 563. https://doi.org/10.1007/s11239-019-01938-2.

MLA (9th ed.) Citation

A, Åkerblom, et al. "Prevalence and Relevance of Abnormal Glucose Metabolism in Acute Coronary Syndromes: Insights from the PLATelet Inhibition and Patient Outcomes (PLATO) Trial." Journal of Thrombosis and Thrombolysis, vol. 48, no. 4, 2019, p. 563, https://doi.org/10.1007/s11239-019-01938-2.